文献速递脑血管病

未破裂颅内动脉瘤合并颅内动脉粥样硬化性狭窄的患病率及操作风险

Prevalence and Procedural Risk of Intracranial Atherosclerotic Stenosis Coexisting With Unruptured Intracranial Aneurysm.
PubMed 文献 · Stroke · 2023-05-04

基于CAIASA研究前瞻性纳入2015年10月至2020年12月北京天坛医院接受治疗的未破裂颅内动脉瘤患者3949例,其中245例(6.2%)合并颅内动脉粥样硬化性狭窄(ICAS,狭窄≥50%)。ICAS患者操作相关缺血性卒中发生率为15.7%(32/204),无ICAS患者为5.0%(141/2825),匹配后校正OR为2.99(1.38-6.48),ICAS评分越高风险越高。

要点

  • 未破裂颅内动脉瘤患者中ICAS患病率为6.2%(245/3949)。
  • ICAS患者操作相关缺血性卒中发生率15.7%(32/204)vs 无ICAS患者5.0%(141/2825)。
  • 匹配后ICAS与操作相关缺血性卒中风险独立相关,校正OR=2.99(1.38-6.48)。

核心结论

  • ICAS在未破裂颅内动脉瘤患者中并不少见,合并ICAS约增加2倍操作相关缺血风险,无论夹闭还是栓塞。
  • 既往抗血小板治疗可能降低该风险。

研究设计与样本

  • 基于CAIASA研究(Coexistence of Atherosclerotic Intracranial Arterial Stenosis With Intracranial Aneurysms)的前瞻性研究,纳入2015年10月至2020年12月北京天坛医院接受治疗操作的未破裂颅内动脉瘤患者。
  • 采用CT血管造影或数字减影血管造影诊断ICAS(狭窄≥50%)。
  • 采用多变量logistic回归和倾向性评分匹配评估ICAS与操作相关缺血性卒中及不良结局的风险。
  • 使用ICAS评分探讨不同ICAS负荷与操作相关缺血风险的关系。

主要发现

  • 3949例接受血管内或开放手术的未破裂颅内动脉瘤患者中,245例(6.2%)合并ICAS。
  • 排除后,ICAS患者操作相关缺血性卒中发生率为15.7%(32/204),无ICAS患者为5.0%(141/2825)。
  • 未匹配队列中ICAS与操作相关缺血性卒中风险增加显著相关,校正OR=3.11(1.89-5.11);匹配队列中校正OR=2.99(1.38-6.48)。
  • 未接受抗血小板治疗的患者中该关联更明显(交互作用P=0.022)。
  • 不同治疗方式下风险相似:夹闭组校正OR=3.43(1.73-6.79),栓塞组校正OR=3.59(1.94-6.65)。

关键数值与推荐

  • ICAS定义为狭窄≥50%,采用CT血管造影或数字减影血管造影诊断。
  • ICAS患者操作相关缺血性卒中15.7%(32/204)vs 无ICAS患者5.0%(141/2825)。
  • 未匹配队列校正OR=3.11(1.89-5.11),匹配队列校正OR=2.99(1.38-6.48)。
  • 夹闭组校正OR=3.43(1.73-6.79),栓塞组校正OR=3.59(1.94-6.65)。
  • 未接受抗血小板治疗者交互作用P=0.022,ICAS评分与风险趋势P<0.001。

临床怎么用

  • 作者认为ICAS在未破裂颅内动脉瘤患者中并不少见,合并ICAS约增加2倍操作相关缺血风险,无论夹闭还是栓塞。
  • 作者认为既往抗血小板治疗可能降低该风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coexistence of intracranial atherosclerotic stenosis (ICAS) and unruptured intracranial aneurysms (UIAs) is increasingly encountered in clinical practice. This study aims to determine the prevalence of ICAS in patients with UIAs and procedural ischemic risk associated with ICAS when treating UIAs. METHODS: Based on the CAIASA study (Coexistence of Atherosclerotic Intracranial Arterial Stenosis With Intracranial Aneurysms), we prospectively included patients undergoing treatment procedures for UIAs from October 2015 to December 2020 at Beijing Tiantan Hospital, China. We used computed tomography angiography or digital subtraction angiography to diagnose ICAS (stenosis≥50%). Multivariable logistic regression and propensity-score matching were performed to evaluate the risk of procedure-related ischemic stroke and unfavorable outcome associated with ICAS. The ICAS score was used to explore the association between different burden of ICAS and procedure-related ischemic risk. RESULTS: Among 3949 patients who underwent endovascular or open surgical procedures for UIAs, 245 (6.2%) had ICAS. After exclusion, 15.7% (32/204) of patients with ICAS experienced procedure-related ischemic stroke compared with 5.0% (141/2825) of patients without ICAS. From the unmatched and matched cohort, ICAS was significantly associated with increased risk of procedure-related ischemic stroke (unmatched: adjusted odds ratio=3.11 [1.89-5.11]; and matched: adjusted odds ratio=2.99 [1.38-6.48]). This association became more evident among patients not receiving antiplatelet therapy (Pinteraction=0.022). For patients undergoing different treatment modalities, similar increased risks were observed (clipping: adjusted odds ratio=3.43 [1.73-6.79]; and coiling: adjusted odds ratio=3.59 [1.94-6.65]). Higher ICAS score was correlated with higher procedural ischemic risk (Ptrend<0.001). CONCLUSIONS: The occurrence of ICAS is not infrequent in patients with UIAs. ICAS confers an ~2-fold increased procedural ischemic risk, irrespective of clipping or coiling. Previous antiplatelet therapy may decrease the risk. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02795078.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Yin Z, Zhang Q, Zhao Y, et al. Prevalence and Procedural Risk of Intracranial Atherosclerotic Stenosis Coexisting With Unruptured Intracranial Aneurysm. Stroke. 2023. PMID: 37139814. doi:10.1161/STROKEAHA.122.041553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。